Sign in

CIK 0001098972

  • Accelerated filer
  • Smaller reporting company
Ticker
AGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061562417
Phone
+1 781-674-4410
Business address
3 FORBES ROAD, LEXINGTON, MA, 02421
Former names
ANTIGENICS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-14 ARMEN GARO H Chairman and CEO Other disposition −159,000 $2.29 $364K 892,155
2020-05-14 ARMEN GARO H Chairman and CEO Other disposition −600,000 $2.29 $1.4M 292,155
2020-05-12 ARMEN GARO H Chairman and CEO Other acquisition +159,000 $2.56 $407K 1,051,155
2020-05-08 ARMEN GARO H Chairman and CEO Grant or award +5,842 $2.53 $15K 892,155
2020-04-24 ARMEN GARO H Chairman and CEO Grant or award +5,296 $2.79 $15K 1,112,282
2020-04-10 ARMEN GARO H Chairman and CEO Grant or award +5,911 $2.50 $15K 1,106,986
2020-04-01 Wright Timothy Director Grant or award · Deferred Stock Units +2,539.45 119,066.37
2020-04-01 WIINBERG ULF Director Grant or award · Deferred Stock Units +8,009.02 75,419.83
2019-06-19 ARMEN GARO H Chairman and CEO Grant or award · Stock Option (Right to buy) +42,500 42,500

Page 18 of 18 · 349 trades